Russian Heart Failure Journal 2011year Veritable prevalence of CHF in the European part of Russian Federation (EPOCHA trial, hospital stage)


To access this material please log in or register

Register Authorize
2011/

Veritable prevalence of CHF in the European part of Russian Federation (EPOCHA trial, hospital stage)

Belenkov Y. N., Mareev V. Y., Ageev F. T., Fomin I. V., Badin Y. V., Polyakov D. S., Danielyan M. O., Artemyeva E. G., Malenkova V. Y., Poroshina E. A., Tarlovskaya E. I., Smirnova E. A., Yakushin S. S. Shcherbinina E. V.

Keywords: hospital stage, EPOCHA trial, prevalence RF, CHF

DOI: 10.18087/rhfj.2011.2.1510

Background. Due to the lack of reliable statistical data on heart failure prevalence in Russian population a well designed epidemiolo­gical trial is required to get a veritable prevalence of CHF in the European part of Russia. Objective. To examine veritable prevalence of CHF in the European part of Russia in out- and inpatients. Materials and methods. On the first stage a representative sample included eight subjects of Russian Federation: Nizhniy Novgorod, Kirov, Voronezh and Ryazan regions, Stavropol Territory, Republic of Tatarstan, Chuvash Republic. 19,503 respondents were included. In order to confirm or to refute CHF diagnosis hospital phase of the trial was conducted. Patients, presumably with CHF according to the first stage, were hospitalized. Inpatients underwent clinical, laboratory and instrumental examination for diagnosis establishment. Results. The veritable prevalence of CHF in Russian Federation is 7 %. CHF is twice more common among women than men due to a factor of survival. The veritable frequency distribution of CHF FC is following: I FC – 22.7 %, II FC – 47.4 %; III FC – 25.1 % and FC IV – 4.8 %. In all age groups men predominate on the frequency distribution in comparison with women, except groups of 30 to 39 years and 70 to 79 years. Heavier class of CHF in the population reduces the number of age groups (grades).
  1. Brophy JM. Epidemiology of congestive heart failure: Canadian data from 1970 to 1989. Can J Cardiol 1992; 8: 495–8.
  2. Remes J, Reunanen A, Aromaa A, Pyorala K. Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J 1992; 13: 588–93.
  3. Eriksson H, Wilhelmsen L, Caidahl K, Svardsudd K. Epidemiology and prognosis of heart failure. Z Kardiol 1991; 80 (Suppl 8): 1–6.
  4. Ho KK, Pinsky JL, Kannel WB et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol. 1993;22 (4 Suppl A):6A-13A.
  5. Royal College of General Practitioners, Office of Population Census and Survey, and Department of Health and Social Security. Morbidity statistics from general practice: third national study, 1981–82. London: HMSO, 1986.
  6. Bonneaux L, Barendregt JJ, Meetr K et al. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: future rise of heart failure. Am J Public Health. 1994;84 (1):20–28.
  7. Cleland J, Swedberg K, Cohen Solal A et al. The EuroHeart Failure Survey of the EUROHEART Survey Programme: a survey on the quality of care among patients with heart failure in Europe. Eur J Heart Fail. 2000;2 (2):123–132.
  8. Davies M, Hobbs F, Davis R et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study. Lancet. 2001;358 (9280):439–444.
  9. Cleland J, Swedberg K, Follath F et al. The IMPROVEMENT of heart failure survey. International variations in the aetiology of heart failure managed in primary care. Eur J Heart Fait. 2001; 3: S72. [Abstract].
  10. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26‑year follow-up of the Framingham population. Am Heart J. 1986;111 (2):383–390.
  11. Mosterd A, Hoes AW, de Bruyne MC et al. Prevalence of heart failure and left ventricular dysfunction in the general population. The Rotterdam Study. Eur Heart J. 1999;20 (6):447–455.
  12. Parameshwar J, Shackell MM, Richardson A et al. Prevalence of heart failure in three general practices in North West London. Br J Gen Pract. 1992;42 (360):287–289.
  13. Wendelboe O, Hansen JF. Prevalence of mild and severe congestive heart failure in the community. Heart Failure ‘95, International Meeting of the Working Group on Heart Failure of the European Society of Cardiology, April 1–4 1995, Amsterdam, (abstr). The Netherlands.
  14. Ambrosio GB, Riva LM, Zamboni S et al. Prevalence of congestive heart failure (CHF) in elderly. A survey from a population in Veneto region. Cardiologia. 1992;37 (10):685–691.
  15. McDonagh T, Morrison C, Lawrence A et al. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350 (9081):829–833.
  16. Мареев В. Ю., Беленков Ю. Н., Агеев Ф. Т. и др. Первые результаты Российского эпидемиологического исследования по ХСН (ЭПОХА–ХСН). Журнал Сердечная Недостаточность. 2003;4 (1):17–18.
  17. Фомин И. В., Беленков Ю. Н., Мареев В. Ю. и др. Распространенность хронической сердечной недостаточности в Европейской части Российской Федерации – данные ЭПОХА–ХСН. Журнал Сердечная Недостаточность. 2006;7 (3):112–115.
  18. Фомин И. В., Беленков Ю. Н., Мареев В. Ю. и др. Распространенность ХСН в Европейской части Российской Федерации – данные ЭПОХА–ХСН. Журнал Сердечная Недостаточность. 2006;7 (1):4–7.
Belenkov YN, Mareev VY, Ageev FT et al. Veritable prevalence of CHF in the European part of Russian Federation (EPOCHA trial, hospital stage). Russian Heart Failure Journal. 2011;12(2):63-68.

To access this material please log in or register

Register Authorize
Ru En